Rituximab Use In Neurosarcoidosis

Update Item Information
Identifier 20180304_nanos_posters_037
Title Rituximab Use In Neurosarcoidosis
Creator Mangayarkarasi Thandampallayam, David Kaufman, Lina Nagia
Subject Miscellaneous
Description Rituximab is a chimeric monoclonal antibody that causes depletion of CD 20+ B cells. There are few documented reports describing successful use of rituximab in refractory neurosarcoidosis. Here we present a case of central nervous system (CNS) sarcoidosis effectively treated with rituximab.
Date 2018-03
Language eng
Format application/pdf
Source 2018 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS 2018: Poster Presentations
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2018. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s62847f4
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Mangayarkarasi Thandampallayam
Contributor Secondary David Kaufman, Lina Nagia
Setname ehsl_novel_nam
ID 1307517
Reference URL https://collections.lib.utah.edu/ark:/87278/s62847f4
Back to Search Results